Form 4: Humana Director Reports Stock Unit Transactions

Humana Inc. director Kurt J. Hilzinger reported transactions involving restricted stock units, including deferrals and dividend reinvestments.

Summary

• Kurt J. Hilzinger, a Director at Humana Inc., has filed a Form 4 detailing changes in his beneficial ownership of company stock.
• The transactions primarily involve restricted stock units (RSUs) granted as annual director fees, dividend payments, and elected cash fee conversions.
• These RSUs have been deferred at Mr. Hilzinger's election and are payable in Humana Inc. common stock on a one-for-one basis upon his resignation as director.
• The filing indicates a total of 19,448 shares of Humana Common stock held directly.
• Additionally, 24,800 RSUs and 3,364 RSUs are held directly, with a further 233 RSUs acquired on June 30, 2026, valued at $392.32 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to compensation and does not indicate significant positive or negative developments for the company.

Positives

• Director Kurt J. Hilzinger continues to hold a significant direct beneficial ownership in Humana Inc. common stock.
• The deferral of RSUs and dividend reinvestments indicate a long-term commitment and alignment with shareholder interests.
• Transactions are structured to comply with Rule 16b-3(d)(1) and 16b-3(d), suggesting adherence to governance best practices for executive compensation.

Negatives

• The filing does not disclose any negative financial performance or operational issues.
• No indication of stock sales or dispositions that would suggest a lack of confidence by the reporting person.

Risks

• The value of deferred stock units is subject to market fluctuations in Humana Inc.'s common stock price.
• Potential for changes in company policy or regulatory environment affecting the value or payout of stock units.

Future Outlook

The future outlook for the reported stock units is tied to the performance of Humana Inc. common stock, with payouts occurring upon the reporting person's resignation as director.

Industry Context

StockSavvy.ai notes that the reporting of stock unit transactions by directors is a standard disclosure practice in the healthcare and insurance industry, reflecting executive compensation structures and insider holdings.

Comparison to Industry Standards

• The structure of director compensation, including the use of deferred stock units and dividend reinvestment, is common among large publicly traded companies in the healthcare sector.
• Companies like UnitedHealth Group and Anthem (now Elevance Health) also utilize similar equity-based compensation plans for their directors and executives.

Corporate Governance

Stakeholder Impact

• Shareholders: The continued holding of stock units by directors aligns management interests with shareholders, potentially signaling confidence in the company's long-term prospects.
• Employees: Indirect impact through the company's overall performance, which is influenced by management's strategic decisions.
• Creditors: No direct impact indicated by this filing.

Next Steps

• Payout of deferred stock units to Kurt J. Hilzinger upon his resignation as director.
• Continued monitoring of Humana Inc.'s stock performance and any further insider transactions.

Key Dates

Keywords

Humana Inc., Form 4, SEC Filing, Director, Stock Units, Restricted Stock Units, Beneficial Ownership, Securities, Insider Trading, Deferred Compensation